Hyep Ivan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$553,198.15

Insider Activity of Hyep Ivan

According to the SEC Form 4 filings, Hyep Ivan, being in a position of

  1. Chief Financial Officer at Bicara Therapeutics Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 114100 shares for $2.57M,
    over all time since 2025-10-06, has bought 0 shares, and sold 150900 shares for $3.24M.

Biography of Hyep Ivan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$2,571,80811100

Comparison of Insiders on Amount of Buys and Sells

2026-08-10SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
12,500
0.0208%
$27.97$349,591-23.4%
2026-07-08SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
28,000
0.0509%
$28.85$807,672-19.49%
2026-05-21SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
9,200
0.0165%
$20.42$187,883+11.06%
2026-04-21SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
9,200
0.0167%
$23.00$211,614-1.56%
2026-03-23SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
9,200
0.0169%
$18.52$170,348+22.97%
2026-03-04SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
2,963
0.0053%
$18.25$54,062+18.66%
2026-03-03SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
13,555
0.0256%
$18.22$246,910+22.71%
2026-01-22SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
1,882
0.0035%
$18.15$34,162+22.06%
2025-12-22SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
9,200
0.0168%
$18.31$168,492+12.23%
2025-11-24SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
17,795
0.0334%
$18.55$330,094+6.01%
2025-11-21SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
605
0.0011%
$18.15$10,981+10.86%
2025-10-09SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
6,415
0.0117%
$18.23$116,931+6.24%
2025-10-08SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
5,627
0.0104%
$18.21$102,456+7.78%
2025-10-07SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
18,244
0.0335%
$18.22$332,386+6.77%
2025-10-06SaleBicara Therapeutics Inc. Common Stock
BCAX
Chief Financial Officer
6,514
0.012%
$18.17$118,356+7.6%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.